Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.

OBJECTIVE: Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in...

Bibliografiset tiedot
Päätekijät:	Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2012

Samankaltaisia teoksia

ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION
Tekijä: Miskowiak, K, et al.
Julkaistu: (2011)

Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2010)

Neural correlates of improved executive function following erythropoietin treatment in mood disorders
Tekijä: Miskowiak, K, et al.
Julkaistu: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
Tekijä: Paulson Olaf B, et al.
Julkaistu: (2010-10-01)

Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder
Tekijä: Miskowiak, K, et al.
Julkaistu: (2018)

Erythropoietin as candidate for supportive treatment of severe COVID-19
Tekijä: Hannelore Ehrenreich, et al.
Julkaistu: (2020-06-01)

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
Tekijä: Søren F. V. Nielsen, et al.
Julkaistu: (2019-11-01)

Erythropoietin enhances hippocampal response during memory retrieval in humans.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2007)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
Tekijä: Jeff Zarp Petersen, et al.
Julkaistu: (2018-11-01)

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2008)

Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression
Tekijä: Miskowiak, K, et al.
Julkaistu: (2017)

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
Tekijä: Maj Vinberg, et al.
Julkaistu: (2015-01-01)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
Tekijä: Ida Seeberg, et al.
Julkaistu: (2018-07-01)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
Tekijä: Miskowiak, K, et al.
Julkaistu: (2009)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
Tekijä: Miskowiak, K, et al.
Julkaistu: (2009)

Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression
Tekijä: Miskowiak, K, et al.
Julkaistu: (2017)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
Tekijä: Lejla Sjanic Schmidt, et al.
Julkaistu: (2018-04-01)

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2009)

Is aberrant affective cognition an endophenotype for affective disorders? A monozygotic twin study
Tekijä: Meluken, I, et al.
Julkaistu: (2018)

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2007)

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2010)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
Tekijä: Kirsa M Demant, et al.
Julkaistu: (2015-01-01)

Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
Tekijä: Kjaerstad, H, et al.
Julkaistu: (2019)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
Tekijä: Lars Vedel Kessing, et al.
Julkaistu: (2018-10-01)

Predictors of mood and activity instability in participants with newly diagnosed bipolar disorder – Exploratory findings from a prospective cohort study
Tekijä: Anton Julius von Hofacker, et al.
Julkaistu: (2024-01-01)

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
Tekijä: Miskowiak, K, et al.
Julkaistu: (2008)

Executive dysfunction and autobiographical memory retrieval in recovered depressed women.
Tekijä: Haddad, A, et al.
Julkaistu: (2014)

Mood and Activity Measured Using Smartphones in Unipolar Depressive Disorder
Tekijä: Morten Lindbjerg Tønning, et al.
Julkaistu: (2021-07-01)

Erythropoietin enhances hippocampal long-term potentiation and memory
Tekijä: El-Kordi Ahmed, et al.
Julkaistu: (2008-09-01)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
Tekijä: Faurholt-Jepsen, M, et al.
Julkaistu: (2019)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
Tekijä: Faurholt-Jepsen, M, et al.
Julkaistu: (2019)

Erythropoietin – a potential tool in the treatment of depressive disorders?
Tekijä: G. Simões, et al.
Julkaistu: (2022-06-01)

Lack of effect of tyrosine depletion on mood in recovered depressed women.
Tekijä: McTavish, S, et al.
Julkaistu: (2005)

Erythropoietin improves operant conditioning and stability of cognitive performance in mice
Tekijä: Ehrenreich Hannelore, et al.
Julkaistu: (2009-07-01)

Immediate Mood Scaler: Tracking Symptoms of Depression and Anxiety Using a Novel Mobile Mood Scale
Tekijä: Nahum, Mor, et al.
Julkaistu: (2017-04-01)

Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
Tekijä: Martin Begemann, et al.
Julkaistu: (2021-09-01)

Latent Classes of Symptoms related to Clinically Depressed Mood in Adolescents
Tekijä: Eva Henje Blom, et al.
Julkaistu: (2014-05-01)

Effects of emotion recognition training on mood among individuals with high levels of depressive symptoms: study protocol for a randomised controlled trial.
Tekijä: Adams, S, et al.
Julkaistu: (2013)

Bipolar mood disorder and treatment-resistant depression
Tekijä: Rybakowski Janusz K
Julkaistu: (2010-04-01)